FARALLON CAPITAL MANAGEMENT, L.L.C. Diversified Active

Location: San Francisco, CA

CIK: 0000909661 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $13.24B

Holdings (99)

— CELGENE CORP 11.7%
Value $1.546B Shares 15,569,730 Share Price $99.30 Est. Cost/Share — Unrealized @ Report Date —
— ALLERGAN PLC 7.9%
Value $1.049B Shares 6,235,000 Share Price $168.29 Est. Cost/Share — Unrealized @ Report Date —
SPY SPDR S&P 500 ETF TR 7.4%
Value $981M Shares 3,306,000 Share Price $296.77 Est. Cost/Share — Unrealized @ Report Date —
— ALTABA INC 5.0%
Value $666M Shares 34,189,499 Share Price $19.48 Est. Cost/Share — Unrealized @ Report Date —
— WELLCARE HEALTH PLANS INC 4.6%
Value $614M Shares 2,368,310 Share Price $259.17 Est. Cost/Share — Unrealized @ Report Date —
WAB WABTEC CORP 3.4%
Value $451M Shares 6,270,986 Share Price $71.86 Est. Cost/Share — Unrealized @ Report Date —
FIS FIDELITY NATL INFORMATION SV 3.1%
Value $406M Shares 3,055,609 Share Price $132.76 Est. Cost/Share — Unrealized @ Report Date —
IQV IQVIA HLDGS INC 3.0%
Value $394M Shares 2,640,179 Share Price $149.38 Est. Cost/Share — Unrealized @ Report Date —
BABA ALIBABA GROUP HLDG LTD 2.7%
Value $364M Shares 2,174,715 Share Price $167.23 Est. Cost/Share — Unrealized @ Report Date —
— IAC INTERACTIVECORP 2.4%
Value $318M Shares 1,457,500 Share Price $217.97 Est. Cost/Share — Unrealized @ Report Date —
GOOG ALPHABET INC 2.3%
Value $305M Shares 250,037 Share Price $1219.00 Est. Cost/Share — Unrealized @ Report Date —
CHTR CHARTER COMMUNICATIONS INC N 2.2%
Value $291M Shares 705,309 Share Price $412.12 Est. Cost/Share — Unrealized @ Report Date —
ELV ANTHEM INC 1.9%
Value $255M Shares 1,062,883 Share Price $240.10 Est. Cost/Share — Unrealized @ Report Date —
SHW SHERWIN WILLIAMS CO 1.9%
Value $247M Shares 449,952 Share Price $549.87 Est. Cost/Share — Unrealized @ Report Date —
META FACEBOOK INC 1.8%
Value $243M Shares 1,363,514 Share Price $178.08 Est. Cost/Share — Unrealized @ Report Date —
— PLAYA HOTELS & RESORTS NV 1.8%
Value $240M Shares 30,606,930 Share Price $7.83 Est. Cost/Share — Unrealized @ Report Date —
— IHS MARKIT LTD 1.8%
Value $239M Shares 3,575,384 Share Price $66.88 Est. Cost/Share — Unrealized @ Report Date —
V VISA INC 1.7%
Value $223M Shares 1,295,257 Share Price $172.01 Est. Cost/Share — Unrealized @ Report Date —
EQIX EQUINIX INC 1.6%
Value $214M Shares 371,670 Share Price $576.80 Est. Cost/Share — Unrealized @ Report Date —
SPGI S&P GLOBAL INC 1.5%
Value $204M Shares 832,314 Share Price $244.98 Est. Cost/Share — Unrealized @ Report Date —
MSFT MICROSOFT CORP 1.5%
Value $197M Shares 1,414,272 Share Price $139.03 Est. Cost/Share — Unrealized @ Report Date —
— CITRIX SYS INC 1.4%
Value $183M Shares 1,900,323 Share Price $96.52 Est. Cost/Share — Unrealized @ Report Date —
GD GENERAL DYNAMICS CORP 1.4%
Value $181M Shares 991,732 Share Price $182.73 Est. Cost/Share — Unrealized @ Report Date —
— ZAYO GROUP HLDGS INC 1.3%
Value $168M Shares 4,944,247 Share Price $33.90 Est. Cost/Share — Unrealized @ Report Date —
CI CIGNA CORP NEW 1.2%
Value $161M Shares 1,062,790 Share Price $151.79 Est. Cost/Share — Unrealized @ Report Date —
— BUCKEYE PARTNERS L P 1.2%
Value $160M Shares 3,900,000 Share Price $41.09 Est. Cost/Share — Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 1.1%
Value $149M Shares 1,550,000 Share Price $96.32 Est. Cost/Share — Unrealized @ Report Date —
PANW PALO ALTO NETWORKS INC 0.9%
Value $124M Shares 610,000 Share Price $203.83 Est. Cost/Share — Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 0.9%
Value $121M Shares 1,500,000 Share Price $80.42 Est. Cost/Share — Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 0.8%
Value $110M Shares 6,025,000 Share Price $18.20 Est. Cost/Share — Unrealized @ Report Date —
AZN ASTRAZENECA PLC 0.8%
Value $106M Shares 2,375,785 Share Price $44.57 Est. Cost/Share — Unrealized @ Report Date —
— MYOKARDIA INC 0.8%
Value $106M Shares 2,030,397 Share Price $52.15 Est. Cost/Share — Unrealized @ Report Date —
SE SEA LTD 0.8%
Value $104M Shares 3,375,000 Share Price $30.95 Est. Cost/Share — Unrealized @ Report Date —
TRU TRANSUNION 0.8%
Value $102M Shares 1,255,138 Share Price $81.11 Est. Cost/Share — Unrealized @ Report Date —
— ACCELERON PHARMA INC 0.7%
Value $94.82M Shares 2,400,000 Share Price $39.51 Est. Cost/Share — Unrealized @ Report Date —
EFX EQUIFAX INC 0.7%
Value $89.33M Shares 635,056 Share Price $140.67 Est. Cost/Share — Unrealized @ Report Date —
— GENESEE & WYO INC 0.7%
Value $86.49M Shares 782,673 Share Price $110.51 Est. Cost/Share — Unrealized @ Report Date —
— ALDER BIOPHARMACEUTICALS INC 0.6%
Value $78.55M Shares 4,165,000 Share Price $18.86 Est. Cost/Share — Unrealized @ Report Date —
— GLOBAL BLOOD THERAPEUTICS IN 0.6%
Value $78.22M Shares 1,612,069 Share Price $48.52 Est. Cost/Share — Unrealized @ Report Date —
— TRINITY MERGER CORP 0.6%
Value $77.28M Shares 75,000,000 Share Price $1.03 Est. Cost/Share — Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.6%
Value $76.56M Shares 1,274,212 Share Price $60.08 Est. Cost/Share — Unrealized @ Report Date —
ABBV ABBVIE INC 0.6%
Value $75.72M Shares 1,000,000 Share Price $75.72 Est. Cost/Share — Unrealized @ Report Date —
— ZOGENIX INC 0.5%
Value $70.07M Shares 1,750,000 Share Price $40.04 Est. Cost/Share — Unrealized @ Report Date —
GRFS GRIFOLS S A 0.5%
Value $62.39M Shares 3,113,222 Share Price $20.04 Est. Cost/Share — Unrealized @ Report Date —
BKNG BOOKING HLDGS INC 0.5%
Value $61.11M Shares 31,139 Share Price $1962.62 Est. Cost/Share — Unrealized @ Report Date —
— CYPRESS SEMICONDUCTOR CORP 0.4%
Value $57.53M Shares 2,464,966 Share Price $23.34 Est. Cost/Share — Unrealized @ Report Date —
CVS CVS HEALTH CORP 0.4%
Value $56.76M Shares 900,000 Share Price $63.07 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.4%
Value $52.9M Shares 2,054,486 Share Price $25.75 Est. Cost/Share — Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.4%
Value $52.3M Shares 372,800 Share Price $140.29 Est. Cost/Share — Unrealized @ Report Date —
— ZYMEWORKS INC 0.3%
Value $42.94M Shares 1,731,500 Share Price $24.80 Est. Cost/Share — Unrealized @ Report Date —
— CARA THERAPEUTICS INC 0.3%
Value $39.3M Shares 2,150,000 Share Price $18.28 Est. Cost/Share — Unrealized @ Report Date —
— SPRINT CORPORATION 0.3%
Value $38.47M Shares 6,234,186 Share Price $6.17 Est. Cost/Share — Unrealized @ Report Date —
— PROGENICS PHARMACEUTICALS IN 0.3%
Value $37.15M Shares 7,350,000 Share Price $5.05 Est. Cost/Share — Unrealized @ Report Date —
— FIBROGEN INC 0.3%
Value $36.98M Shares 1,000,000 Share Price $36.98 Est. Cost/Share — Unrealized @ Report Date —
NXPI NXP SEMICONDUCTORS N V 0.3%
Value $35.46M Shares 325,000 Share Price $109.12 Est. Cost/Share — Unrealized @ Report Date —
RC READY CAP CORP 0.3%
Value $35.11M Shares 2,205,132 Share Price $15.92 Est. Cost/Share — Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 0.3%
Value $34.94M Shares 2,250,000 Share Price $15.53 Est. Cost/Share — Unrealized @ Report Date —
UBER UBER TECHNOLOGIES INC 0.3%
Value $33.59M Shares 1,102,500 Share Price $30.47 Est. Cost/Share — Unrealized @ Report Date —
— CYPRESS SEMICONDUCTOR CORP 0.2%
Value $32.58M Shares 18,645,000 Share Price $1.75 Est. Cost/Share — Unrealized @ Report Date —
EXEL EXELIXIS INC 0.2%
Value $30.95M Shares 1,750,000 Share Price $17.69 Est. Cost/Share — Unrealized @ Report Date —
— AMARIN CORP PLC 0.2%
Value $30.33M Shares 2,000,600 Share Price $15.16 Est. Cost/Share — Unrealized @ Report Date —
— ZEALAND PHARMA A S 0.2%
Value $25.61M Shares 1,010,000 Share Price $25.36 Est. Cost/Share — Unrealized @ Report Date —
— DECIPHERA PHARMACEUTICALS IN 0.2%
Value $25.45M Shares 750,000 Share Price $33.94 Est. Cost/Share — Unrealized @ Report Date —
— PTC THERAPEUTICS INC 0.2%
Value $25.21M Shares 24,176,000 Share Price $1.04 Est. Cost/Share — Unrealized @ Report Date —
— INVITAE CORP 0.2%
Value $25.05M Shares 1,300,000 Share Price $19.27 Est. Cost/Share — Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 0.2%
Value $24.59M Shares 726,986 Share Price $33.82 Est. Cost/Share — Unrealized @ Report Date —
— SYMANTEC CORP 0.2%
Value $24.34M Shares 1,030,000 Share Price $23.63 Est. Cost/Share — Unrealized @ Report Date —
VCYT VERACYTE INC 0.2%
Value $24M Shares 1,000,000 Share Price $24.00 Est. Cost/Share — Unrealized @ Report Date —
— STEMLINE THERAPEUTICS INC 0.2%
Value $23.94M Shares 2,300,000 Share Price $10.41 Est. Cost/Share — Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 0.2%
Value $23.37M Shares 300,000 Share Price $77.91 Est. Cost/Share — Unrealized @ Report Date —
CRSP CRISPR THERAPEUTICS AG 0.2%
Value $22.97M Shares 560,367 Share Price $40.99 Est. Cost/Share — Unrealized @ Report Date —
— AVROBIO INC 0.2%
Value $21.89M Shares 1,550,000 Share Price $14.12 Est. Cost/Share — Unrealized @ Report Date —
— SPARK THERAPEUTICS INC 0.2%
Value $21.34M Shares 220,000 Share Price $96.98 Est. Cost/Share — Unrealized @ Report Date —
— PIVOTAL SOFTWARE INC 0.2%
Value $21.34M Shares 1,430,000 Share Price $14.92 Est. Cost/Share — Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS IN 0.1%
Value $18.32M Shares 650,000 Share Price $28.18 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.1%
Value $18.02M Shares 1,500,000 Share Price $12.01 Est. Cost/Share — Unrealized @ Report Date —
— SOLARCITY CORP 0.1%
Value $17.18M Shares 17,370,000 Share Price $0.99 Est. Cost/Share — Unrealized @ Report Date —
— TRICIDA INC 0.1%
Value $15.44M Shares 500,000 Share Price $30.87 Est. Cost/Share — Unrealized @ Report Date —
— REATA PHARMACEUTICALS INC 0.1%
Value $14.62M Shares 182,060 Share Price $80.29 Est. Cost/Share — Unrealized @ Report Date —
— MELLANOX TECHNOLOGIES LTD 0.1%
Value $13.7M Shares 125,000 Share Price $109.59 Est. Cost/Share — Unrealized @ Report Date —
— CHEMOCENTRYX INC 0.1%
Value $13.65M Shares 2,013,396 Share Price $6.78 Est. Cost/Share — Unrealized @ Report Date —
— QUOTIENT LTD 0.1%
Value $13.21M Shares 1,700,000 Share Price $7.77 Est. Cost/Share — Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 0.1%
Value $12.6M Shares 350,000 Share Price $35.99 Est. Cost/Share — Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 0.1%
Value $11.53M Shares 1,125,000 Share Price $10.25 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 0.1%
Value $9.304M Shares 3,510,787 Share Price $2.65 Est. Cost/Share — Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 0.1%
Value $8.261M Shares 18,801,000 Share Price $0.44 Est. Cost/Share — Unrealized @ Report Date —
AXSM AXSOME THERAPEUTICS INC 0.1%
Value $8.096M Shares 400,000 Share Price $20.24 Est. Cost/Share — Unrealized @ Report Date —
XGN EXAGEN INC 0.0%
Value $5.628M Shares 363,336 Share Price $15.49 Est. Cost/Share — Unrealized @ Report Date —
— PFENEX INC 0.0%
Value $5.064M Shares 600,000 Share Price $8.44 Est. Cost/Share — Unrealized @ Report Date —
— CYCLERION THERAPEUTICS INC 0.0%
Value $4.565M Shares 376,628 Share Price $12.12 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 0.0%
Value $3.972M Shares 100,922 Share Price $39.36 Est. Cost/Share — Unrealized @ Report Date —
— SANOFI 0.0%
Value $3.892M Shares 6,827,805 Share Price $0.57 Est. Cost/Share — Unrealized @ Report Date —
DMTKQ DERMTECH INC 0.0%
Value $3.446M Shares 615,385 Share Price $5.60 Est. Cost/Share — Unrealized @ Report Date —
— PHASEBIO PHARMACEUTICALS INC 0.0%
Value $3.369M Shares 807,928 Share Price $4.17 Est. Cost/Share — Unrealized @ Report Date —
— APTINYX INC 0.0%
Value $2.353M Shares 674,141 Share Price $3.49 Est. Cost/Share — Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.0%
Value $1.691M Shares 100,712 Share Price $16.79 Est. Cost/Share — Unrealized @ Report Date —
— II VI INC 0.0%
Value $1.679M Shares 47,687 Share Price $35.21 Est. Cost/Share — Unrealized @ Report Date —
— ZAFGEN INC 0.0%
Value $1.336M Shares 1,808,360 Share Price $0.74 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.0%
Value $1.14M Shares 1,250,000 Share Price $0.91 Est. Cost/Share — Unrealized @ Report Date —